L
Luca Stingeni
Researcher at University of Perugia
Publications - 233
Citations - 3040
Luca Stingeni is an academic researcher from University of Perugia. The author has contributed to research in topics: Medicine & Atopic dermatitis. The author has an hindex of 21, co-authored 189 publications receiving 1751 citations.
Papers
More filters
Journal ArticleDOI
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Torsten Zuberbier,Amir Hamzah Abdul Latiff,Mohamed Abuzakouk,S. Aquilina,Riccardo Asero,Diane Baker,Barbara Ballmer-Weber,Barbara Ballmer-Weber,Christine Bangert,Moshe Ben-Shoshan,Jonathan A. Bernstein,Carsten Bindslev-Jensen,Knut Brockow,Zenon Brzoza,Herberto José Chong Neto,Martin K. Church,Martin K. Church,Paulo Ricardo Criado,I V Danilycheva,Corinna Dressler,Luis Felipe Ensina,Luz Fonacier,Matthew Gaskins,Krisztián Gáspár,Aslı Gelincik,A. Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Martine Grosber,Eckard Hamelmann,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,Aharon Kessel,Emek Kocatürk,Kanokvalai Kulthanan,Désirée Larenas-Linnemann,Antti Lauerma,Tabi A. Leslie,Markus Magerl,Markus Magerl,Michael Makris,R. Y. Meshkova,Martin Metz,Martin Metz,Daniel Micallef,Charlotte G. Mortz,Alexander Nast,Hanneke Oude-Elberink,Ruby Pawankar,Paolo D. Pigatto,Hector Ratti Sisa,María Isabel Rojo Gutiérrez,Sarbjit S. Saini,Peter Schmid-Grendelmeier,Bulent Enis Sekerel,Frank Siebenhaar,Frank Siebenhaar,Hanna Siiskonen,Angèle Soria,Petra Staubach-Renz,Luca Stingeni,Gordon Sussman,Andrea Szegedi,Simon Francis Thomsen,Zahava Vadasz,Christian Vestergaard,Bettina Wedi,Zuotao Zhao,Marcus Maurer,Marcus Maurer +72 more
TL;DR: This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) on 3 December 2020 as mentioned in this paper, with the participation of 64 delegates of 50 national and international societies and from 31 countries.
Journal ArticleDOI
Occupational hand dermatitis in hospital environments.
TL;DR: Assessment of the prevalence and clinical relevance of contact dermatitis in employees of the Perugia Monteluce Hospital found atopy seemed to favour the onset of hand dermatitis, and the importance of these results for preventive measures of contact Dermatitis in hospital employees is discussed.
Journal ArticleDOI
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.
Paolo Gisondi,Gianfranco Altomare,Fabio Ayala,Federico Bardazzi,Luca Bianchi,Andrea Chiricozzi,Antonio Costanzo,Andrea Conti,Paolo Dapavo,C. De Simone,Caterina Foti,Luigi Naldi,A. Offidani,Andrea Parodi,Stefano Piaserico,Francesca Prignano,Franco Rongioletti,Luca Stingeni,Marina Talamonti,Giampiero Girolomoni +19 more
TL;DR: Recommendations on the treatment of psoriasis in special patient populations were agreed and the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatologists and Venereology psorosis guidelines.
Journal ArticleDOI
Italian Guidelines in Patch Testing - adapted from the European Society of Contact Dermatitis (ESCD).
Luca Stingeni,Leonardo Bianchi,Katharina Hansel,Monica Corazza,Rosella Gallo,Fabrizio Guarneri,Cataldo Patruno,Luigi Rigano,Paolo Romita,Paolo D. Pigatto,Piergiacomo Calzavara-Pinton,Sidapa +11 more
TL;DR: These guidelines for the best practice in performing patch test have been developed by an Italian group of experts taking in account the Italian legislation and local pharmacological governance.
Journal ArticleDOI
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients
Angelo V. Marzano,Angelo V. Marzano,Giovanni Genovese,Giovanni Genovese,Giovanni Casazza,M.T. Fierro,Paolo Dapavo,Nunzio Crimi,Silvia Ferrucci,Patrizia Pepe,Serena Liberati,Paolo D. Pigatto,A. Offidani,Emanuela Martina,Giampiero Girolomoni,M. Rovaris,Caterina Foti,Luca Stingeni,Antonio Cristaudo,G.W. Canonica,Eustachio Nettis,Riccardo Asero +21 more
TL;DR: Omalizumab is a monoclonal anti‐IgE antibody effective in refractory CSU, but its mechanism of action and markers predictive of response remain not completely defined.